BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34918244)

  • 21. A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus.
    Zhou YH; Purcell RH; Emerson SU
    Vaccine; 2005 May; 23(24):3157-65. PubMed ID: 15837215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of ORF2 protein of HEV genotype IV in Hansenula polymorpha].
    Su CX; Gu MR; Zhang P; Jin ZJ; Meng FH; Chen EJ; Yang Z; Liu Y; Wang YC
    Sheng Wu Gong Cheng Xue Bao; 2007 Jan; 23(1):73-8. PubMed ID: 17366891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The putative capsid protein of the newly identified avian hepatitis E virus shares antigenic epitopes with that of swine and human hepatitis E viruses and chicken big liver and spleen disease virus.
    Haqshenas G; Huang FF; Fenaux M; Guenette DK; Pierson FW; Larsen CT; Shivaprasad HL; Toth TE; Meng XJ
    J Gen Virol; 2002 Sep; 83(Pt 9):2201-2209. PubMed ID: 12185274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Arginine-Rich Motif in the ORF2 capsid protein regulates the hepatitis E virus lifecycle and interactions with the host cell.
    Hervouet K; Ferrié M; Ankavay M; Montpellier C; Camuzet C; Alexandre V; Dembélé A; Lecoeur C; Foe AT; Bouquet P; Hot D; Vausselin T; Saliou JM; Salomé-Desnoulez S; Vandeputte A; Marsollier L; Brodin P; Dreux M; Rouillé Y; Dubuisson J; Aliouat-Denis CM; Cocquerel L
    PLoS Pathog; 2022 Aug; 18(8):e1010798. PubMed ID: 36007070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis E virus (HEV) open reading frame 2: Role in pathogenesis and diagnosis in HEV infections.
    Sayed IM; Karam-Allah Ramadan H; Hafez MHR; Elkhawaga AA; El-Mokhtar MA
    Rev Med Virol; 2022 Nov; 32(6):e2401. PubMed ID: 36209386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the C-terminal cysteines in virus-like particle formation and oligomerization of the hepatitis E virus ORF2 truncated proteins.
    Liu Z; Behloul N; Baha S; Wei W; Tao W; Zhang T; Li W; Shi R; Meng J
    Virology; 2020 May; 544():1-11. PubMed ID: 32174509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis E Virus Capsid as a Carrier of Exogenous Antigens for the Development of Chimeric Virus-Like Particles.
    Lu T; Behloul N; Zhou Y; Baha S; Liu Z; Wei W; Shi RH; Meng J
    Intervirology; 2022; 65(1):37-48. PubMed ID: 34695827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatial configuration of hepatitis E virus antigenic domain.
    Xing L; Wang JC; Li TC; Yasutomi Y; Lara J; Khudyakov Y; Schofield D; Emerson SU; Purcell RH; Takeda N; Miyamura T; Cheng RH
    J Virol; 2011 Jan; 85(2):1117-24. PubMed ID: 21068233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of B-cell epitopes in the capsid protein of avian hepatitis E virus (avian HEV) that are common to human and swine HEVs or unique to avian HEV.
    Guo H; Zhou EM; Sun ZF; Meng XJ; Halbur PG
    J Gen Virol; 2006 Jan; 87(Pt 1):217-223. PubMed ID: 16361434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies.
    Riddell MA; Li F; Anderson DA
    J Virol; 2000 Sep; 74(17):8011-7. PubMed ID: 10933710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4.
    Huang WJ; Zhang HY; Harrison TJ; Lan HY; Huang GY; Wang YC
    Arch Virol; 2009; 154(3):481-8. PubMed ID: 19240977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production and characterization of a fusion form of hepatitis E virus
    Boumaiza M; Trabelsi K; Choucha Z; Akrouti I; Leone S; Picone D; Kallel H
    Prep Biochem Biotechnol; 2021; 51(6):562-569. PubMed ID: 33095097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production and characterization of a Brazilian candidate antigen for Hepatitis E Virus genotype 3 diagnosis.
    de Almeida Ramos D; Miani M; Pandolfi R; Tondo L; Colli ML; Rosado Spilki F; Rovaris Gardinali N; Alves Pinto M; Kreutz LC; Frandoloso R
    FEMS Microbiol Lett; 2016 Mar; 363(5):fnw021. PubMed ID: 26832642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral Vaccination with Hepatitis E Virus Capsid Protein and Immunobiotic Bacterium-Like Particles Induce Intestinal and Systemic Immunity in Mice.
    Arce LP; Raya Tonetti MF; Raimondo MP; Müller MF; Salva S; Álvarez S; Baiker A; Villena J; Vizoso Pinto MG
    Probiotics Antimicrob Proteins; 2020 Sep; 12(3):961-972. PubMed ID: 31630331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
    Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA
    Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs.
    Sanford BJ; Opriessnig T; Kenney SP; Dryman BA; Córdoba L; Meng XJ
    Vaccine; 2012 Sep; 30(44):6249-55. PubMed ID: 22906724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in
    Yang Z; Gao F; Wang X; Shi L; Zhou Z; Jiang Y; Ma X; Zhang C; Zhou C; Zeng X; Liu G; Fan J; Mao Q; Shi L
    Hum Vaccin Immunother; 2020 Jul; 16(7):1602-1610. PubMed ID: 31403352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vectorial Release of Hepatitis E Virus in Polarized Human Hepatocytes.
    Capelli N; Marion O; Dubois M; Allart S; Bertrand-Michel J; Lhomme S; Abravanel F; Izopet J; Chapuy-Regaud S
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenic Characterization of ORF2 and ORF3 Proteins of Hepatitis E Virus (HEV).
    Pezzoni G; Stercoli L; Pegoiani E; Brocchi E
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemistry for hepatitis E virus capsid protein cross-reacts with cytomegalovirus-infected cells: a potential diagnostic pitfall.
    Lenggenhager D; Grossmann J; Gouttenoire J; Sempoux C; Weber A
    Histopathology; 2023 Jan; 82(2):354-358. PubMed ID: 36148841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.